Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05552222 |
|---|---|
| Brief Title: | A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma (MajesTEC-7) |
| First Submitted : | September 21, 2022 |
| First Submitted that Met QC Criteria : | September 21, 2022 |
| First Posted : | September 23, 2022 |
| Last Update Submitted that Met QC Criteria : | April 23, 2024 |
| Last Update Posted : | April 24, 2024 |